Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Homeostatic role of B-1 cells in tissue immunity. | Front Immunol | 2023 | 37744333 | PubTator, text mining | PubMed |
| The future of affordable cancer immunotherapy. | Front Immunol | 2023 | 37736099 | PubTator, text mining | PubMed |
| Regulatory factor X1 induces macrophage M1 polarization by promoting DNA demethylation in autoimmune inflammation. | JCI Insight | 2023 | 37733446 | PubTator, text mining | PubMed |
| Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning. | Front Genet | 2023 | 37732314 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia. | Sci Rep | 2023 | 37730831 | PubTator, text mining | PubMed |
| mRNA vaccines in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37726283 | PubTator, text mining | PubMed |
| Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials. | Front Pharmacol | 2023 | 37719852 | PubTator, text mining | PubMed |
| Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? | Front Oncol | 2023 | 37711206 | PubTator, text mining | PubMed |
| Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients. | Front Immunol | 2023 | 37701444 | PubTator, text mining | PubMed |
| The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report. | Cancer Manag Res | 2023 | 37700812 | PubTator, text mining | PubMed |
| Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma. | Cancer Manag Res | 2023 | 37700809 | PubTator, text mining | PubMed |
| Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes. | J Cancer Res Clin Oncol | 2023 | 37688630 | PubTator, text mining | PubMed |
| Marine Natural Compound (Neviotin A) Displays Anticancer Efficacy by Triggering Transcriptomic Alterations and Cell Death in MCF-7 Cells. | Molecules | 2023 | 37687120 | PubTator, text mining | PubMed |
| Development and Validation of the Oxidative Stress Related lncRNAs for Prognosis in Esophageal Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37686677 | PubTator, text mining | PubMed |
| The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma. | Cancers (Basel) | 2023 | 37686584 | PubTator, text mining | PubMed |
| Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities. | Int J Mol Sci | 2023 | 37686020 | PubTator, text mining | PubMed |
| Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations. | Cells | 2023 | 37681880 | PubTator, text mining | PubMed |
| Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells. | iScience | 2023 | 37674985 | PubTator, text mining | PubMed |
| CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them. | Hemasphere | 2023 | 37674860 | PubTator, text mining | PubMed |
| The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. | JCI Insight | 2023 | 37669110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=27